CoMind and Benchmark partner to develop non-invasive brain monitoring device

CoMind is joining with Benchmark to develop and produce a groundbreaking, non-invasive brain monitoring device, as featured in the Financial Times. CoMind’s device uses low-powered lasers to measure cerebral blood flow and pressure non-invasively, offering a safer alternative to traditional methods. Founder James Dacombe says, “The brain is the most important organ that you have and yet it’s the least monitored at the patient bedside.” Board member Michael Tarnoff adds, “None of this has ever been done before and it all holds the promise of dramatically changing care standards while reducing costs and improving outcomes." https://lnkd.in/g87YnXuh